Indolo[3,2-c]quinoline compounds
US8273760B2 · kind B2 · utility
0Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 31, 2009 |
| Grant date | Sep 25, 2012 |
| Priority date | — |
| Expiry date | Jun 9, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are indolo[3,2-c]quinoline compounds of formula (I):or a pharmaceutically acceptable salt thereof,wherein R and m are given the definitions as set forth in the Specification and Claims.These compounds can be used to inhibit both growth of cancer cells and activity of telomerase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.